Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ila Mishra

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Elife|April 27, 2021
Asprosin-neutralizing antibodies as a treatment for metabolic syndromeIla Mishra, Clemens Duerrschmid, Zhiqiang Ku, et al.
Cell Metabolism|March 17, 2022
Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptorIla Mishra, Wei Rose Xie, Juan C Bournat, et al.
Nature Neuroscience|July 10, 2024
The cerebellum modulates thirstIla Mishra, Bing Feng, Bijoya Basu, et al.
Research Square|June 29, 2026
Asprosin-PTPRD endocrine resistance links brain dysfunction and systemic wasting in Alzheimer's diseaseAtul Chopra, Bijoya Basu, Hesong Liu, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Elife|April 27, 2021
Asprosin-neutralizing antibodies as a treatment for metabolic syndromeIla Mishra, Clemens Duerrschmid, Zhiqiang Ku, et al.
Cell Metabolism|March 17, 2022
Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptorIla Mishra, Wei Rose Xie, Juan C Bournat, et al.
Nature Neuroscience|July 10, 2024
The cerebellum modulates thirstIla Mishra, Bing Feng, Bijoya Basu, et al.
Research Square|June 29, 2026
Asprosin-PTPRD endocrine resistance links brain dysfunction and systemic wasting in Alzheimer's diseaseAtul Chopra, Bijoya Basu, Hesong Liu, et al.
Pageof 3